Lung Cancers Completed Phase 1 Trials for Gefitinib (DB00317)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00310154Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerTreatment
NCT00005806Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment